The Role of the C-Reactive Protein-Triglyceride Glucose Index in Predicting New-Onset Chronic Diseases: Evidence From a Longitudinal Cohort Study - PubMed
5 hours ago
- #biomarker
- #chronic diseases
- #longitudinal study
- The C-reactive protein-triglyceride glucose index (CTI) is a biomarker reflecting systemic inflammation and insulin resistance.
- A longitudinal study of 9,275 participants assessed CTI's association with 14 chronic diseases, including hypertension, diabetes, and stroke.
- Elevated CTI levels significantly increased risks of new-onset hypertension, dyslipidemia, diabetes, stroke, and liver disease.
- Nonlinear associations were found between CTI and osteoarthritis as well as stroke.
- CTI shows potential as a clinical risk assessment tool for predicting chronic diseases.